NovoCure (NVCR) Non-Current Assets (2014 - 2026)
NovoCure recorded quarterly Non-Current Assets of $156.3 million in Q1 2026, down 0.85% quarter-over-quarter from $157.6 million in Q4 2025, and down 2.03% year-over-year from $159.5 million in Q1 2025.
NovoCure's Non-Current Assets history runs 13 years deep, the most recent figure standing at $156.3 million for Q1 2026.
- In Q1 2026, Non-Current Assets fell 2.03% year-over-year to $156.3 million; the TTM figure through Mar 2026 stood at $156.3 million (down 2.03% YoY), while the FY2025 annual figure was $157.6 million, up 17.43% from the prior year.
- Non-Current Assets came in at $156.3 million for Q1 2026 at NovoCure, down from $157.6 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $162.6 million in Q2 2025 to a low of $68.1 million in Q2 2022.
- A 5-year average of $116.2 million and a median of $118.7 million in 2024 frame the typical range for Non-Current Assets.
- Across the five-year window, Non-Current Assets soared 39.64% in 2022 and declined 2.03% in 2026, its largest moves.
- NovoCure's Non-Current Assets stood at $80.1 million in 2022, then soared by 39.44% to $111.7 million in 2023, then climbed by 20.13% to $134.2 million in 2024, then advanced by 17.43% to $157.6 million in 2025, then decreased by 0.85% to $156.3 million in 2026.
- According to Business Quant data, Non-Current Assets over the past three periods registered $156.3 million, $157.6 million, and $161.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 84.92 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 32.95 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 67.41 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 35.67 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 7.09 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 20.47 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 2.30 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 26.70 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 8.34 Bn |
| 10 | NovoCure | 1.90 Bn | 1.47 Bn | 135.13 Mn | 156.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 156.26 Mn |
| Dec 31, 2025 | 157.60 Mn |
| Sep 30, 2025 | 161.34 Mn |
| Jun 30, 2025 | 162.58 Mn |
| Mar 31, 2025 | 159.51 Mn |
| Dec 31, 2024 | 134.21 Mn |
| Sep 30, 2024 | 126.72 Mn |
| Jun 30, 2024 | 119.33 Mn |
| Mar 31, 2024 | 118.72 Mn |
| Dec 31, 2023 | 111.72 Mn |
| Sep 30, 2023 | 98.35 Mn |
| Jun 30, 2023 | 93.53 Mn |
| Mar 31, 2023 | 85.35 Mn |
| Dec 31, 2022 | 80.12 Mn |
| Sep 30, 2022 | 71.84 Mn |
| Jun 30, 2022 | 68.12 Mn |
| Mar 31, 2022 | 69.63 Mn |
| Dec 31, 2021 | 65.97 Mn |
| Sep 30, 2021 | 51.45 Mn |
| Jun 30, 2021 | 51.49 Mn |
| Mar 31, 2021 | 52.39 Mn |
| Dec 31, 2020 | 52.54 Mn |
| Sep 30, 2020 | 47.56 Mn |
| Jun 30, 2020 | 41.16 Mn |
| Mar 31, 2020 | 40.27 Mn |
| Dec 31, 2019 | 39.50 Mn |
| Sep 30, 2019 | 36.92 Mn |
| Jun 30, 2019 | 15.87 Mn |
| Mar 31, 2019 | 34.58 Mn |
| Dec 31, 2018 | 15.37 Mn |
| Sep 30, 2018 | 15.86 Mn |
| Jun 30, 2018 | 19.99 Mn |
| Mar 31, 2018 | 17.92 Mn |
| Dec 31, 2017 | 18.07 Mn |
| Sep 30, 2017 | 20.39 Mn |
| Jun 30, 2017 | 20.55 Mn |
| Mar 31, 2017 | 19.32 Mn |
| Dec 31, 2016 | 18.62 Mn |
| Sep 30, 2016 | 17.93 Mn |
| Jun 30, 2016 | 15.82 Mn |
| Mar 31, 2016 | 15.38 Mn |
| Dec 31, 2015 | 12.58 Mn |
| Sep 30, 2015 | 10.62 Mn |
| Dec 31, 2014 | 6.05 Mn |